QT
RYTM icon

Quantbot Technologies’s Rhythm Pharmaceuticals RYTM Stock Holding History

Quantbot Technologies’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Buy
+1,363
New +$133K ﹤0.01% 1290
2025
Q4 		– Sell
-4,981
Closed -$503K – 2106
2025
Q3 		$503K Buy
+4,981
New +$462K 0.01% 1018
2024
Q2 		– Sell
-3,600
Closed -$156K – 1854
2024
Q1 		$156K Sell
3,600
-4,400
-55% -$193K 0.01% 1071
2023
Q4 		$368K Buy
+8,000
New +$252K 0.02% 824
2022
Q2 		– Sell
-2,538
Closed -$29K – 2073
2022
Q1 		$29K Buy
+2,538
New +$22.3K ﹤0.01% 1305
2020
Q1 		– Sell
-1,463
Closed -$33K – 1312
2019
Q4 		$33K Buy
+1,463
New +$32.5K ﹤0.01% 998
2018
Q3 		– Sell
-4,826
Closed -$150K – 1514
2018
Q2 		$150K Buy
+4,826
New +$132K 0.01% 791

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Quantbot Technologies's RYTM Position: Q1 2026 in Review

Quantbot Technologies opened a new position in Rhythm Pharmaceuticals (RYTM) in Q1 2026: 1,363 shares worth $119K. The stake represents ﹤0.01% of the portfolio and ranks #1290 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in RYTM as recently as Q3 2025.

Quantbot Technologies first reported a position in RYTM in Q2 2018 and has held it in 7 quarters since. The position peaked at $503K in Q3 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Quantbot Technologies held 1,363 shares of Rhythm Pharmaceuticals worth $119K as of Q1 2026.
  • Rhythm Pharmaceuticals was a new Quantbot Technologies position in Q1 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1290 holding.
  • Quantbot Technologies first reported a position in Rhythm Pharmaceuticals in Q2 2018 and has held it in 7 quarters since.
  • Quantbot Technologies's Rhythm Pharmaceuticals position peaked at $503K in Q3 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.